Foamix will present the successful results from its Phase II clinical trials with topical minocycline for acne and impetigo at the 34th Annual Cowen & Company Health Care Conference.

The pharmaceutical company, which focuses on the development of patented topical foams for dermatology, announced that Chief Executive Officer, Dr.Dov Tamarkin, will speak at the conference. Dr. Tamarkin will discuss the results from the Phase II acne and impetigo clinical trials. He will also explain the company's transition from a technology-based company into a commercially based.

Presentation Details: Monday, March 3, 2014 at 3:30 p.m. EST. Held at the Boston Marriott Copley Place in Boston, Massachusetts.